The medication commonly causes gastrointestinal side effects including nausea, vomiting, and abdominal discomfort, particularly during initial treatment
In this context, targeted, case-specific exceptions for evidence-based obesity treatment can be a measured approach that supports employee health while allowing plan sponsors to thoughtfully evaluate whether existing exclusions remain appropriate as standards continue to evolve
PlexusDx's Precision Peptide Genetic Test reveals predispositions in these peptide pathwaysnot as a predictor of exact medication response, but as context for your provider conversation
[8] Fat redistribution due to semaglutide can lead to a hollowed-out or sagging appearance, particularly in the cheeks, temples, and around the eyes, while excess fat may accumulate in areas such as the jowls and under the chin
During those early clinical trials, researchers observed an unexpected and significant side effect: substantial weight loss among study participants
When supplementing with glutathione to correct glutathione deficiency or maintain optimal levels, supplement daily
